Cognitive and neurobehavioral profile in boys with duchenne muscular dystrophy

Journal of Child Neurology

Volumn 30, Issue 11, 2015, Pages 1472-1482

  Banihani, Rudaina ^a,b,c   Smile, Sharon ^a,b,c,d   Yoon, Grace ^c   Dupuis, Annie ^a,e   Mosleh, Maureen ^b   Snider, Andrea ^b   McAdam, Laura ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOLLAND BLOORVIEW KIDS REHABILITATION HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d University of Toronto   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

behavioral and developmental disorders; cognitive impairment; Dp140 isoform; Dp71 isoforms; Duchenne muscular dystrophy

Indexed keywords

DYSTROPHIN; ISOPROTEIN;

5' UNTRANSLATED REGION; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; COGNITION; COMORBIDITY; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; GENETICS; INFANT; INTELLIGENCE; INTELLIGENCE TEST; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NEUROPSYCHOLOGICAL TEST; PRESCHOOL CHILD; PREVALENCE; PSYCHOLOGY; RETROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; COGNITION; COMORBIDITY; DYSTROPHIN; HUMANS; INFANT; INTELLIGENCE; INTELLIGENCE TESTS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROTEIN ISOFORMS; RETROSPECTIVE STUDIES;

EID: 84937599698     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073815570154     Document Type: Article

References (93)

1. Mento G, Tarantino V, Bisiacchi PS,. The neuropsychological profile of infantile Duchenne muscular dystrophy. Clin Neuropsychol. 2011; 25 (8): 1359-1377.
2. Hoffman EP, Brown RH Jr, Kunkel LM,. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987; 51 (6): 919-928.
3. Bresolin N, Castelli E, Comi GP, et al. Cognitive impairment in Duchenne muscular dystrophy. Neuromuscul Disord. 1994; 4 (4): 359-369.
4. Kumagai T, Miura K, Ohki T, et al. [Central nervous system involvements in Duchenne/Becker muscular dystrophy]. No To Hattatsu. 2001; 33 (6): 480-486.
5. Pellegrini C,. Melanocytes: a new potential tool to study and monitoring Duchenne muscular dystrophy. Tesi Di Dottorato. 2012.
6. Hendriksen JGM, Vles JSH,. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol. 2008; 23 (5): 477-481.
7. Poysky J, Behavior in DMDSG. Behavior patterns in Duchenne muscular dystrophy: report on the Parent Project Muscular Dystrophy behavior workshop 8-9 of December 2006, Philadelphia, USA. Neuromuscul Disord. 2007; 17 (11-12): 986-994.
8. Felisari G, Martinelli F, Robotti M, et al. [Mental retardation in Duchenne muscular dystrophy patients deleted in the distal domain of the gene: effect of unexpressed Dp 140 apo-dystrophin?]. SAGGI-Neuropsicologia Infantile Psicopedagogia Riabilitazione. 1998; 24 (2): 83-88.
9. Donders J, Taneja C,. Neurobehavioral characteristics of children with Duchenne muscular dystrophy. Child Neuropsychol. 2009; 15 (3): 295-304.
10. Cotton SM, Voudouris NJ, Greenwood KM,. Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis. Dev Med Child Neurol. 2005; 47 (4): 257-265.
11. Hinton VJ, De Vivo DC, Fee R, Goldstein E, Stern Y,. Investigation of poor academic achievement in children with Duchenne muscular dystrophy. Learning Disabilities Res Pract. 2004; 19 (3): 146-154.
12. Wingeier K, Giger E, Strozzi S, et al. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011; 18 (1): 90-95.
13. Pane M, Lombardo ME, Alfieri P, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr. 2012; 161 (4): 705-709e1.
14. Sollee ND, Latham EE, Kindlon DJ, Bresnan MJ,. Neuropsychological impairment in Duchenne muscular dystrophy. J Clin Exp Neuropsychol. 1985; 7 (5): 486-496.
15. Lidov HG, Selig S, Kunkel LM,. Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995; 4 (3): 329-335.
16. Felisari G, Martinelli Boneschi F, Bardoni A, et al. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology. 2000; 55 (4): 559-564.
17. Ricotti V, Mandy WPL, Robb SA, Skuse DH, Muntoni F,. Neurobehavioural profile of Duchenne muscular dystrophy. Dev Med Child Neurol. 2012; 54: 96.
18. Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C,. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998; 80 (1): 32-41.
19. Morris GE, Simmons C, Man NT,. Apo-dystrophins (DP140 and DP71) and dystrophin splicing isoforms in developing brain. Biochem Biophys Res Comm. 1995; 215 (1): 361-367.
20. Kreis R, Wingeier K, Vermathen P, et al. Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy. NMR Biomed. 2011; 24 (3): 253-262.
21. Cotton S, Voudouris NJ, Greenwood KM,. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001; 43 (7): 497-501.
22. Dorman C, Hurley AD, D'Avignon J,. Language and learning disorders of older boys with Duchenne muscular dystrophy. Dev Med Child Neurol. 1988; 30 (3): 316-327.
23. Marsh GG, Munsat TL,. Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Childhood. 1974; 49 (2): 118-122.
24. Worden DK, Vignos PJ Jr,. Intellectual function in childhood progressive muscular dystrophy. Pediatrics. 1962; 29: 968-977.
25. Vignos PJ Jr,. Intellectual function and educational achievement in Duchenne muscular dystrophy. Isr J Med Sci. 1977; 13 (2): 215-222.
26. Billard C, Gillet P, Barthez M, Hommet C, Bertrand P,. Reading ability and processing in Duchenne muscular dystrophy and spinal muscular atrophy. Dev Med Child Neurol. 1998; 40 (1): 12-20.
27. Leibowitz D, Dubowitz V,. Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981; 23 (5): 577-590.
28. Hinton VJ, De Vivo DC, Nereo NE, Goldstein E, Stern Y,. Poor verbal working memory across intellectual level in boys with Duchenne dystrophy. Neurology. 2000; 54 (11): 2127-2132.
29. Hinton VJ, Fee RJ, Goldstein EM, De Vivo DC,. Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2007; 49 (2): 123-128.
30. Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE,. Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr. 2006; 27 (6): 470-476.
31. Steele M, Taylor E, Young C, McGrath P, Lyttle BDB, Davidson B,. Mental health of children and adolescents with Duchenne muscular dystrophy. Dev Med Child Neurol. 2008; 50 (8): 638-639.
32. Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS,. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007; 161 (9): 857-864.
33. Taylor PJ, Betts GA, Maroulis S, et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLOS ONE. 2010; 5 (1): e8803.
34. Komoto J, Usui S, Otsuki S, Terao A,. Infantile autism and Duchenne muscular dystrophy. J Autism Dev Disord. 1984; 14 (2): 191-195.
35. Hinton VJ, Fee RJ, De Vivo DC, Goldstein E,. Poor facial affect recognition among boys with Duchenne muscular dystrophy. J Autism Developmental Disord. 2007; 37 (10): 1925-1933.
36. Wu JY, Kuban KCK, Allred E, Shapiro F, Darras BT,. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005; 20 (10): 790-795.
37. Zwaigenbaum L, Tarnopolsky M,. Two children with muscular dystrophies ascertained due to referral for diagnosis of autism. J Autism Dev Disord. 2003; 33 (2): 193-199.
38. Hinton VJ, Cyrulnik SE, Fee RJ, et al. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol. 2009; 41 (5): 339-346.
39. Blumberg SJ, Bramlett MD, Kogan MD, et al. Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012. http://www.cdc.gov/nchs/data/nhsr/nhsr065.pdf 2013.
40. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR. 2009; 58 (10): 1-20.
41. Polakoff RJ, Morton AA, Koch KD, Rios CM,. The psychosocial and cognitive impact of Duchenne's muscular dystrophy. Semin Pediatr Neurol. 1998; 5 (2): 116-123.
42. Roccella M, Pace R, De Gregorio MT,. Psychopathological assessment in children affected by Duchenne de Boulogne muscular dystrophy. Minerva Pediatr. 2003; 55 (3): 267-273,. 73-76.
43. Steinhausen HC, Von Gontard A, Spohr HL, et al. Behavioral phenotypes in four mental retardation syndromes: fetal alcohol syndrome, Prader-Willi syndrome, fragile X syndrome, and tuberosis sclerosis. Am J Med Genet. 2002; 111 (4): 381-387.
44. Sargent J, Liebman R,. Childhood chronic illness: issues for psychotherapists. Community Ment Health J. 1985; 21 (4): 294-311.
45. Wechsler D,. Wechsler Intelligence Scale for Children 4. San Antonio, TX: Harcourt Assessment; 2003.
46. Wechsler D,. Wechsler Preschool and Primary Scale of Intelligence 3. San Antonio, TX: Harcourt Assessment; 2002.
47. Climie ERK., Test review: Wechsler Adult Intelligence Scale. J Psychoeducational Assess. 2011; 29 (6): 581-586.
48. Nelson WM III, Dacey CM,. Validity of the Stanford-Binet Intelligence Scale-IV: its use in young adults with mental retardation. Ment Retard. 1999; 37 (4): 319-325.
49. Roid GH, Miller LJ,. Leiter International Performance Scale-Revised. Wood Dale, IL: Stoelting; 1995.
50. Roid GH, Miller LJ,. Leiter International Performance Scale-Revised: Examiner's manual. In Roid GH, Miller LJ, eds. Leiter International Performance Scale-Revised. Wood Dale, IL: Stoelting; 1997.
51. Portoghese C, Buttiglione M, De Giacomo A, et al. Leiter-R versus developmental quotient for estimating cognitive function in preschoolers with pervasive developmental disorders. Neuropsychiatric Dis Treatment. 2010; 6: 337-342.
52. Tsatsanis KD, Dartnall N, Cicchetti D, Sparrow SS, Klin A, Volkmar FR,. Concurrent validity and classification accuracy of the Leiter and Leiter-R in low-functioning children with autism. J Autism Dev Disord. 2003; 33 (1): 23-30.
53. Wechsler D., Wechsler Individual Achievement Test 2nd Edition (WIAT II). London, UK: Psychological Corp; 2005.
54. Lyon GR,. Learning disabilities. Future of Children. 1996; 6 (1): 54-76.
55. Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011; 128 (5): 1007-1022.
56. American Association of Intellectual and Developmental Disabilities. Definition of intellectual disability. Available at: http://aaidd.org/intellectual-disability/definition.
57. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
58. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.,. text revision. Washington, DC: American Psychiatric Association; 2000.
59. Conners CK,. Conners 3rd Edition. Toronto, Canada: Multi-Health Systems; 2008.
60. Conners CK, Sitarenios G, Parker JD, Epstein JN,. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998; 26 (4): 257-268.
61. Conners CK, Sitarenios G, Parker JD, Epstein JN,. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998; 26 (4): 279-291.
62. Heaton SC, Reader SK, Preston AS, et al. The Test of Everyday Attention for Children (TEA-Ch): patterns of performance in children with ADHD and clinical controls. Child Neuropsychol. 2001; 7 (4): 251-264.
63. Lord C, Risi S, Lambrecht L, et al. The Autism Diagnostic Observation Schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord. 2000; 30 (3): 205-223.
64. Torpy JM, Burke AE, Golub RM,. JAMA patient page. Generalized anxiety disorder. JAMA. 2011; 305 (5): 522.
65. Karagan NJ, Zellweger HU,. Early verbal disability in children with Duchenne muscular dystrophy. Dev Med Child Neurol. 1978; 20 (4): 435-441.
66. Cyrulnik SE, Fee RJ, Batchelder A, Kiefel J, Goldstein E, Hinton VJ,. Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc. 2008; 14 (5): 853-861.
67. Bushby K, Finkel R, Birnkrant DJ, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010; 9 (1): 77-93.
68. Pane M, Lombardo ME, Alfieri P, et al. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr. 2012; 161: 705-709.
69. Idiazabal-Alecha MA, Kosno M,. [Attention deficit hyperactivity disorder and epilepsy in childhood]. Revista de neurologia. 2012; 54 (suppl 1): S89-S93.
70. Hoza B,. Peer functioning in children with ADHD. Ambulatory Pediatr. 2007; 7 (1 suppl): 101-106.
71. Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B,. Effects of chronic prednisone therapy on mood and memory. J Affective Disord. 2007; 99 (1-3): 279-283.
72. Kessler RC, Avenevoli S, Costello EJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012; 69 (4): 372-380.
73. Ruscio AM, Stein DJ, Chiu WT, Kessler RC,. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010; 15 (1): 53-63.
74. Pine DS, Cohen P, Gurley D, Brook J, Ma Y,. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 1998; 55 (1): 56-64.
75. Woodward LJ, Fergusson DM,. Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry. 2001; 40 (9): 1086-1093.
76. Kaplow JB, Curran PJ, Angold A, Costello EJ,. The prospective relation between dimensions of anxiety and the initiation of adolescent alcohol use. J Clin Child Psychol. 2001; 30 (3): 316-326.
77. Kendall PC, Compton SN, Walkup JT, et al. Clinical characteristics of anxiety disordered youth. J Anxiety Disord. 2010; 24 (3): 360-365.
78. Ramsawh HJ, Chavira DA, Stein MB,. Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda. Arch Pediatr Adolesc Med. 2010; 164 (10): 965-972.
79. Zafeiriou DI, Ververi A, Vargiami E,. Childhood autism and associated comorbidities. Brain Dev. 2007; 29 (5): 257-272.
80. Pliszka SR,. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatric Clin North Am. 2000; 9 (3): 525-540, vii.
81. Mehler MF,. Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev. 2000; 32 (1): 277-307.
82. Anderson JL, Head SI, Rae C, Morley JW,. Brain function in Duchenne muscular dystrophy. Brain. 2002; 125 (pt 1): 4-13.
83. Cyrulnik SE, Fee RJ, De Vivo DC, Goldstein E, Hinton VJ,. Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr. 2007; 150 (5): 474-478.
84. Lee JS, Pfund Z, Juhasz C, et al. Altered regional brain glucose metabolism in Duchenne muscular dystrophy: a pet study. Muscle Nerve. 2002; 26 (4): 506-512.
85. Elhalal A, Davelaar EJ, Usher M,. The role of the frontal cortex in memory: an investigation of the Von Restorff effect. Front Human Neurosci. 2014; 8: 410.
86. RA B., Executive Functions: What They Are, How They Work, and Why They Evolved. New York, NY: Guilford; 2012.
87. Lidov HG, Kunkel LM,. Dp140: alternatively spliced isoforms in brain and kidney. Genomics. 1997; 45 (1): 132-139.
88. D'Angelo MG, Lorusso ML, Civati F, et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011; 45 (5): 292-299.
89. Jancsik V, Hajos F,. Differential distribution of dystrophin in postsynaptic densities of spine synapses. NeuroReport. 1998; 9 (10): 2249-2251.
90. Moizard MP, Toutain A, Fournier D, et al. Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 2000; 8 (7): 552-556.
91. Doorenweerd N, Straathof CS, Dumas EM, et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol. 2014; 76 (3): 403-411.
92. Haenggi T, Soontornmalai A, Schaub MC, Fritschy JM,. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience. 2004; 129 (2): 403-413.
93. Sarig R, Mezger-Lallemand V, Gitelman I, et al. Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development. Hum Mol Genet. 1999; 8 (1): 1-10.